Close
Nordic 9Nordic 9

AMR Action Fund (investor - Venture Capital)

United States amractionfund.com
See something wrong or missing? Let us know
Offices:Boston

AMR Action Fund is an American VC fund investing in companies developing innovative treatments for priority drug-resistant pathogens

Average round investment:45.34M USD
Average number per year:1.0
Distribution: 2024 (1)2023 (1)2022 (1)
Portfolio companies: United Kingdom F2GFrance AntabioSwitzerland BioVersys
Mostly invests in: United Kingdom United Kingdom (1) Biotech (3)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to AMR Action Fund

Name Criteria
France Xerys
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Switzerland Debiopharm Innovation Fund
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: France, Switzerland
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Singapore Clay Capital
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Sweden Niklas Zennström
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
France eureKARE
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Germany Creathor Venture
72%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
France Malakoff Humanis
72%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
Germany Bastian Nominacher
72%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
United Kingdom Air Street Capital
72%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: France, Switzerland
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
Belgium Sambrinvest
72%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Top